Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis.
Sugiyama Y, Yamamoto K, Honda T, Kato A, Muto H, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Asano T, Enomoto A, Zaitsu K, Ishigami M, Fujishiro M, Kawashima H.
Sugiyama Y, et al. Among authors: asano t.
Hepatol Int. 2023 Dec;17(6):1378-1392. doi: 10.1007/s12072-023-10581-2. Epub 2023 Sep 4.
Hepatol Int. 2023.
PMID: 37666952